Atomoxetine for the Treatment of Cannabis Dependence

NCT00167297 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

NIH

Sponsor class

Conditions

Cannabis Dependence

Interventions

DRUG: Atomoxetine

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]